About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Profile
Schools
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Scientometrics
Avg Impact Factor
h-index
g-index
★★
Articles
★★★
Articles
exaly
›
Institutions
›
Tufts Center for the Study of Drug Development
›
Top Articles
Tufts Center for the Study of Drug Development
United States of America
(csdd.tufts.edu)
241
(top 24%)
articles
11.7K
(top 15%)
citations
53
(top 21%)
★★
articles
8
(top 10%)
★★★
articles
2.7
(top 17%)
Avg IF
40
(top 18%)
H-Index
106
(top 12%)
G-Index
76
journals
Most Cited Articles of Tufts Center for the Study of Drug Development in 2011
Title
Journal
Year
Citations
Pharmaceutical innovation in the 21st century: new drug approvals in the first decade, 2000-2009
Clinical Pharmacology and Therapeutics
2011
236
Antibody-based therapeutics to watch in 2011
MAbs
2011
184
Competitiveness in follow-on drug R&D: a race or imitation?
Nature Reviews Drug Discovery
2011
75
Measuring the Incidence, Causes, and Repercussions of Protocol Amendments
Drug Information Journal
2011
36
A dearth of new meds
Scientific American
2011
28
Patient access to new cancer drugs in the United States and Australia
Value in Health
2011
23
Variability in Protocol Design Complexity by Phase and Therapeutic Area
Drug Information Journal
2011
19
FDA's risk evaluation and mitigation strategies (REMS): effective and efficient safety tools or process poltergeist?
Food and Drug Law Journal
2011
4
Factors Influencing Investigative Site Willingness and Ability to Participate in Clinical Trials
Drug Information Journal
2011
3
Are Pharmacists a Viable Channel for Education about Clinical Trial Participation?
Drug Information Journal
2011
2
Personalized medicine: are payers the weak link?
Personalized Medicine
2011
1
Biopharmaceutical industry perspectives on the business prospects for personalized medicine
Personalized Medicine
2011
1
A New Mechanism for Tracking Publicly Available Study Volunteer Demographics
Drug Information Journal
2011
1
The Promise and Progress of DIA 2011
Drug Information Journal
2011
site/software ©
exaly
; All materials licenced under
CC by-SA
.